Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients

C. Silvia, M. Pallante, S. Vejbaesya, M. Hee Park, C. Saltini, M. Amicosante (Rome, Italy; Bangkok, Thailand; Seoul, Republic Of Korea)

Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Session: Immunology of tuberculosis and diagnosis of tuberculosis infection
Session type: Oral Presentation
Number: 4639
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Silvia, M. Pallante, S. Vejbaesya, M. Hee Park, C. Saltini, M. Amicosante (Rome, Italy; Bangkok, Thailand; Seoul, Republic Of Korea). Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients. Eur Respir J 2006; 28: Suppl. 50, 4639

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mycobacterium tuberculosis (MTB) content in the air of in-patient facility for the management of pulmonary tuberculosis (TB)
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001

Express diagnostics of mycobacterium tuberculosis (MBT) drug resistance at disseminated tuberculosis (DT)
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001

The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS)
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001

Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006



Latent tuberculosis
Source: Respipedia Article
Year: 2018

Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001

Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Identification of nontuberculous mycobacteria (NTM) isolated from patients from the TB hospital
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


TB in migrants
Source: Eur Respir Mon 2012; 58: 194-205
Year: 2012


Velocity of sputum conversion during the treatment of tuberculosis (TB)
Source: Eur Respir J 2006; 28: Suppl. 50, 857s
Year: 2006

What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009